TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Eurocine Vaccines AB
Closing information (x1000 DKK)
| Closing information | 2023/06 (consolidated) | 2022/06 (consolidated) | 2021/06 (consolidated) |
| Turnover |
0
|
0 | |
| Financial expenses |
3
|
4 | |
| Earnings before taxes |
-14,039
|
-13,406 | |
| EBITDA |
-14,036
|
-13,402 | |
| Total assets |
13,090
|
26,265 | |
| Current assets |
13,090
|
26,265 | |
| Current liabilities |
2,239
|
2,829 | |
| Equity capital |
10,851
|
23,436 | |
| - share capital |
3,024
|
1,450 | |
| Employees (average) |
3
|
4
|
4 |
Financial ratios
| Fiscal year | 2023/06 (consolidated) | 2022/06 (consolidated) | 2021/06 (consolidated) |
| Solvency |
82.9%
|
89.2% | |
| Turnover per employee |
0
|
0 | |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-107.2%
|
-51.0% | |
| Current ratio |
584.6%
|
928.4% | |
| Return on equity (ROE) |
-129.4%
|
-57.2% | |
| Change turnover |
0
|
0 | |
| Change turnover % | |||
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-25%
|
0%
|
33% |
Total value of public sale
| Fiscal year | 2023/06 (consolidated) | 2022/06 (consolidated) | 2021/06 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.